A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy
K.A.O. Ellem(QIMR Berghofer Medical Research Institute), Richard C. Mulligan(Whitehead Institute for Biomedical Research), Christopher Schmidt(QIMR Berghofer Medical Research Institute), L. Cohen, Glenn Dranoff(Dana-Farber Cancer Institute), Michael F. Good(Griffith University), A Fell(QIMR Berghofer Medical Research Institute), Denis J. Moss(The University of Queensland), Anne Kelso(Centers for Disease Control and Prevention), Gordon Parry, Scott R. Burrows(Australian National University), Chung‐Leung Li(QIMR Berghofer Medical Research Institute), Simone Cross(QIMR Berghofer Medical Research Institute), Gregory R. Johnson(The Royal Melbourne Hospital), Philip J. Dubois(Mater Private Hospital), Michael G. E. OʼRourke(Mater Adult Hospital), Peter G. Parsons(Queen's University Belfast), I S Misko(QIMR Berghofer Medical Research Institute), JOHN R. BELL(Mater Adult Hospital)
Cited by 101
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
Engineering vascularized skeletal muscle tissue
|Nature Biotechnology|2005|1.3k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996